The platform combines structured data with proprietary AI models, focusing on domain-specific knowledge rather than general internet data. While the company occasionally uses foundational models like OpenAI for certain applications, its core chemistry models are internally developed. The funding round also saw participation from TCV, Index Ventures, F-Prime, and Homebrew. Albert Invent aims to revolutionize chemistry research by implementing advanced AI technology, with its platform becoming integral to product development for companies like Nouryon.
Key takeaways:
- Albert Invent has developed an AI platform called Albert Breakthrough, which is trained on data from past chemical experiments to assist chemists in formulating chemicals more efficiently.
- The startup secured a $22.5 million Series A funding round led by Coatue, with participation from TCV, Index Ventures, F-Prime, and Homebrew.
- Albert Invent's platform is used by major chemical companies like Chemours, Solenis, Keystone Industries, Applied Molecules, Henkel, and Nouryon to enhance product development and generate real-time toxicology predictions.
- The company was incubated within Henkel Corporation and spun out as a separate entity, with its foundational models trained on over 15 million chemical structures.